Axsome Therapeutics, Inc. · 3 hours ago
2026 Summer Intern: Pharmacovigilance Department
Axsome Therapeutics is a biopharmaceutical company focused on treating central nervous system conditions. They are seeking an intern to support the Pharmacovigilance team, assisting with drug information research, data analysis, and understanding regulatory requirements.
BiopharmaBiotechnologyTherapeutics
Responsibilities
Perform drug information research and /or presentations to extend the understanding of Axsome products
Research and understand the disease, symptoms, and treatment of various CNS disorders
Extensive research of drug addiction vs abuse
Participate in data analysis in MedDRA coding for ICSR assessment and some potential safety topics analysis for evaluation
Understand the process of vendor management
Participate in literature review
Review applicable Health Authority regulations and ICH guidelines to optimize current Axsome practices aligning with regulatory requirements and industry standards
Opportunity to initiate or be assigned to pharmacovigilance projects
Additional responsibilities as assigned
Qualification
Required
Actively enrolled with a minimum 3.0 GPA in an undergraduate or graduate program with a focus on a medical field e.g., nursing, neuroscience, psychology, psychiatry, biology, pharmacy, etc
A proactive, creative, and entrepreneurial approach to work
Interest and/or experience in CNS diseases
Excellent oral and written communication skills
Demonstrates strong attention to detail
Proficient in Microsoft Office Suite (Excel, Word, PowerPoint)
Organizational and critical thinking skills
Strong interpersonal skills and the ability to work well in a team environment
Ability to work on site Monday, Tuesday & Thursday. We are unable to consider candidates who are looking for fully remote roles
Experience and knowledge in literature screening for potential literature case or MOA of potential drug adverse reaction
Interest in Pharmaceutical/Life Sciences industry a plus
Accomplished background demonstrating teamwork, creativity, leadership, good judgement, and delivering results
Company
Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc.
Funding
Current Stage
Public CompanyTotal Funding
$1B2025-05-13Post Ipo Debt· $570M
2023-06-28Post Ipo Equity· $225M
2019-12-23Post Ipo Equity· $200M
Recent News
2026-01-01
Company data provided by crunchbase